Skip to main content

and
  1. No Access

    Article

    Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neural markers

    This study extends the application of the digoxigenin-anti-digoxigenin (DIG) technique to immunocytochemistry by using digoxigenin-tagged primary antibodies. Certain features of this technique when applied to ...

    Wolfgang Härtig, Gert Brückner, Max Holzer, Kurt Brauer in Histochemistry and Cell Biology (1995)

  2. No Access

    Article

    Dephosphorylation of Tau Protein by Calcineurin Triturated into Neural Living Cells

    Alzheimer disease and related dementia are characterized by the presence of hyperphosphorylated tau aggregated into filaments. The role of tau phosphorylation in the fibrillogenesis has not yet been unraveled....

    Qun Wei, Max Holzer, Martina K. Brueckner, Yu Liu in Cellular and Molecular Neurobiology (2002)

  3. No Access

    Article

    Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus

    Neurofibrillary degeneration, one of the pathological hallmarks of Alzheimer's disease, is not ubiquitous to all brain regions or neurons. While a high degree of vulnerability has been documented for entorhin...

    Max Holzer, Ulrich Gärtner, Andrea Stöbe, Wolfgang Härtig in Acta Neuropathologica (2002)

  4. Article

    Open Access

    Axotrophin a RING-variant domain protein acts as E3-ubiquitin-ligase and ubiquitinates the microtubule-associated protein tau

    Katharina Flach, Franziska Albrecht, Ellen Ramminger, Thomas Arendt in BMC Neuroscience (2007)

  5. Article

    Open Access

    Alterations in cell cycle profile and cell cycle protein expression in neuroblastoma cells stably transfected with tau protein

    Max Holzer, Franziska Albrecht, Jens Stieler, Cathleen Haase in BMC Neuroscience (2007)

  6. No Access

    Article

    Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

    Some Aβ peptides contain pyroglutamate modifications that affect the aggregation properties of these peptides. The authors find that the enzyme glutaminyl cyclase is responsible for this pyroglutamate modifica...

    Stephan Schilling, Ulrike Zeitschel, Torsten Hoffmann, Ulrich Heiser in Nature Medicine (2008)

  7. No Access

    Article

    Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer’s disease pathology

    Sporadic Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disorder of unknown cause characterized by fibrillar accumulation of the Aß-peptide and aggregates of the microtubule-associated pro...

    Thomas Arendt, Jens Stieler, Max Holzer in Journal of Neural Transmission (2015)

  8. Article

    Open Access

    TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole

    Amyotrophic lateral sclerosis (ALS) represents a fatal neurodegenerative disease, which is characterized by a rapid loss of lower and upper motor neurons. As a major neuropathological hallmark, protein aggrega...

    Moritz Oberstadt, Jens Stieler, David Larbi Simpong, Ute Römuß in Scientific Reports (2018)

  9. No Access

    Article

    TDP-43 and Cytoskeletal Proteins in ALS

    Amyotrophic lateral sclerosis (ALS) represents a rapidly progressing neurodegenerative disease and is characterized by a degeneration of motor neurons. Motor neurons are particularly susceptible to selective a...

    Moritz Oberstadt, Joseph Claßen, Thomas Arendt, Max Holzer in Molecular Neurobiology (2018)

  10. Article

    Open Access

    A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

    Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is neuropathologically characterized by degeneration of dopaminergic neurons of the substantia nigra (SN) and formation of Lewy bodies ...

    Maike Hartlage-Rübsamen, Alexandra Bluhm, Sandra Moceri in Acta Neuropathologica (2021)

  11. Article

    Open Access

    Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport

    The microtubule-associated protein tau plays a central role in tauopathies such as Alzheimer’s disease (AD). The exact molecular mechanisms underlying tau toxicity are unclear, but aging is irrefutably the big...

    Christian Conze, Marina Rierola, Nataliya I. Trushina in Molecular Psychiatry (2022)

  12. Article

    Open Access

    A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice

    Hyperphosphorylation and intraneuronal aggregation of the microtubule-associated protein tau is a major pathological hallmark of Alzheimer’s disease (AD) brain. Of special interest is the effect of cerebral am...

    Susan Barendrecht, An Schreurs, Stefanie Geissler in Alzheimer's Research & Therapy (2023)